The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model
Open accessAbstract
Biofilms represent a niche for microorganisms where they are protected from both the host immune system and antimicrobial therapies. Biofilm growth serves as an increasing source of clinical infections. Candida infections are difficult to manage due to their persistent nature and associated drug resistance. Observations made in biofilm research have generally been limited to in vitro models. Using a rat central venous catheter model, we characterized in vivo Candida albicans biofilm development. Time-course quantitative culture demonstrated a progressive increase in the burden of viable cells for the first 24 h of development. Fluorescence and scanning electron microscopy revealed a bilayered architecture. Adjacent to the catheter surface, yeast cells were densely embedded in an extracellular matrix. The layer adjacent to the catheter lumen was less dense. The outermost surface of the biofilm contained both yeast and hyphal forms, and the extracellular material in which they were embedded appeared fibrous. These architectural features were similar in many respects to those described for in vitro models. However, scanning electron microscopy also revealed host cells embedded within the biofilm matrix. Drug susceptibility was determined by using two assays and demonstrated a biofilm-associated drug resistance phenotype. The first assay demonstrated continued growth of cells in the presence of supra-MIC antifungal drug concentrations. The second assay demonstrated reduced susceptibility of biofilm-grown cells following removal from the biofilm structure. Lastly, the model provided sufficient nucleic material for study of differential gene expression associated with in vivo biofilm growth. Two fluconazole efflux pumps, CDR1 and CDR2 , were upregulated in the in vivo biofilm-associated cells. Most importantly, the studies described provide a model for further investigation into the molecular mechanisms of C. albicans biofilm biology and drug resistance. In addition, the model provides a means to study novel drug therapies and device technologies targeted to the control of biofilm-associated infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A well-established rat central venous catheter infection model (32) was used for in vivo biofilm modeling to mimic human catheter infections as described previously (32).”
From A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans (2014) · cites this paper as [32]
In the citing paper
“A well-established rat central venous catheter infection model (32) was used for in vivo biofilm modeling to mimic human catheter infections as described previously (32).”
From A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans (2014) · cites this paper as [32]
In the citing paper
“Experiments were conducted using male rats as no sex bias has been observed in this model, thus reducing the extraneous use of animals82,83.”
From Adhesin Als4112 promotes Candida auris skin colonization through interactions with keratinocytes and extracellular matrix proteins (2025) · cites this paper as [82]
In the citing paper
“While under treatment with antifungals, biofilm cells up-regulate these transporters within six hours of surface contact both in vitro and in vivo, even in the absence of drug [136,137,138,139].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [139]
In the citing paper
“Biofilm architectures in rat and rabbit central venous and indwelling urinary catheter models and in rat denture stomatitis models also include numerous yeast cells in the basal region, and hyphae and extracellular matrix extending throughout the biofilm (5, 84, 131, 134, 166, 173, 199).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [5]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Bustin, S. A. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,844
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Microbial Biofilms: from Ecology to Molecular Genetics
Davey, M. E., & O’Toole, G. A. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.847-867.2000 · Cited by 3,184
Handbook of fluorescent probes and research chemicals
Haugland, R. P. (1996) · Medical Entomology and Zoology · Cited by 2,793
Cited by
Sorted by citations
Items 101–116 of 116
Xu, Y., Chen, L., & Li, C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn015 · Cited by 104
Dual action antifungal small molecule modulates multidrug efflux and TOR signaling
Shekhar-Guturja, T., Gunaherath, G. M. K. B., Wijeratne, E. M. K., Lambert, J.-P., Averette, A. F., Lee, S. C., Kim, T., Bahn, Y.-S., Tripodi, F., Ammar, R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2165 · Cited by 101
Self-citationConserved and Divergent Roles of Bcr1 and CFEM Proteins in Candida parapsilosis and Candida albicans
Ding, C., Vidanes, G. M., Maguire, S. L., Guida, A., Synnott, J. M., Andes, D. R., & Butler, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028151 · Cited by 93
Self-citationA Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans
Nobile, C. J., Fox, E. P., Hartooni, N., Mitchell, K. F., Hnisz, D., Andes, D. R., Kuchler, K., & Johnson, A. D. (2014) · mBio · doi:10.1128/mbio.01201-14 · Cited by 87
“A well-established rat central venous catheter infection model (32) was used for in vivo biofilm modeling to mimic human catheter infections as described previously (32).”
BackgroundMethodSelf-citationTurbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking
Zhao, M., Zhang, F., Zarnowski, R., Barns, K., Jones, R., Fossen, J., Sanchez, H., Rajski, S. R., Audhya, A., Bugni, T. S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145123 · Cited by 62
Self-citationDalal, C. K., Zuleta, I. A., Mitchell, K. F., Andes, D. R., El-Samad, H., & Johnson, A. D. (2016) · eLife · doi:10.7554/elife.18981 · Cited by 62
Self-citationA common vesicle proteome drives fungal biofilm development
Zarnowski, R., Sanchez, H., Jaromin, A., Zarnowska, U. J., Nett, J. E., Mitchell, A. P., & Andes, D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211424119 · Cited by 63
Self-citationJohnson, C. J., Kernien, J. F., Hoyer, A. R., & Nett, J. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-13588-6 · Cited by 58
Self-citationRat Indwelling Urinary Catheter Model of Candida albicans Biofilm Infection
Nett, J. E., Brooks, E. G., Cabezas-Olcoz, J., Sanchez, H., Zarnowski, R., Marchillo, K., & Andes, D. R. (2014) · Infection and Immunity · doi:10.1128/iai.02284-14 · Cited by 58
Self-citationPaiva, L. C. F., Vidigal, P. G., Donatti, L., Svidzinski, T. I. E., & Consolaro, M. E. L. (2012) · Micron · doi:10.1016/j.micron.2011.09.013 · Cited by 55
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Kim, K., Zilbermintz, L., & Martchenko, M. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0090-4 · Cited by 48
Ahmadi, M. S., Lee, H. H., Sanchez, D. A., Friedman, A. J., Tar, M. T., Davies, K. P., Nosanchuk, J. D., & Martinez, L. R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02659-15 · Cited by 41
Sircaik, S., Román, E., Bapat, P., Lee, K. K., Andes, D. R., Gow, N. A. R., Nobile, C. J., Pla, J., & Panwar, S. L. (2021) · Cellular Microbiology · doi:10.1111/cmi.13307 · Cited by 41
Self-citationZhao, G., Lyu, J., Veniaminova, N. A., Zarnowski, R., Mattos, E., Johnson, C. J., Quintanilla, D., Hautau, H., Hold, L. A., Xu, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60876-1 · Cited by 32
Self-citationCruz, M. R., Cristy, S., Guha, S., De Cesare, G. B., Evdokimova, E., Sanchez, H., Borek, D., Miramón, P., Yano, J., Fidel, P. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33613-1 · Cited by 30
Self-citationZhao, G., Lyu, J., Veniaminova, N. A., Zarnowski, R., Mattos, E., Johnson, C. J., Quintanilla, D., Hautau, H., Hold, L. A., Xu, B., et al. (2025) · doi:10.1101/2025.02.13.637978 · Cited by 2
Self-citation
Metadata
- Authors
- Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A.
- Affiliations
- Department of Medicine
- Biological and Biomaterials Preparation, Imaging, and Characterization Laboratory, Department of Animal Science, University of Wisconsin, Madison, Wisconsin
- University of Wisconsin–Madison (US)
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2004-10
- Volume
- 72
- Issue
- 10
- Pages
- 6023-6031
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC517581
- OpenAlex
- W2149218811
- Cited by
- 389
- References
- 62
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 12 · 2023: 18 · 2022: 16 · 2021: 12 · 2020: 13 · 2019: 15 · 2018: 22 · 2017: 28 · 2016: 28 · 2015: 26 · 2014: 23 · 2013: 19 · 2012: 21
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (K08AI001767, R01AI073289)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, biofilm, central venous catheters, catheter-related infection, antifungal resistance, extracellular matrix, CDR1, CDR2, gene expression, biofilm structure
- MeSH terms
- Animals, Candida albicans, Candidiasis, Catheterization, Central Venous, Female, Genes, Fungal, Kidney, RNA, Fungal, RNA, Messenger, Sonication, Time Factors, Transcription, Genetic, Fluconazole, Gene Expression Regulation, Fungal, Rats, Sprague-Dawley, Biofilms, Microscopy, Confocal, Models, Animal, Drug Resistance, Fungal, Hyphae, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
